Clinical Trial Update: A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the investigational cellular therapy GCAR1 for alveolar soft part sarcoma, but the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Sarcoma

Drugs mentioned

• GCAR1

Snippet

Sponsor: University of Calgary | Conditions: Alveolar Soft Part Sarcoma (ASPS), Sarcoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING